Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,176–6,200 of 7,816 matching trials · page 248 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Imaging of Cognition, Learning, and Memory in Aging NCT01297114 Florbetaben Runs in: United States · 1 site |
NA other |
COMPLETED | 294 | Yaakov Stern OTHER |
2017-11-01 |
|
Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants NCT02792179 [18F]RO6958948 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 4 | Hoffmann-La Roche INDUSTRY |
2017-11-01 |
|
Metabolomic Study in Huntington's Disease (METABO-HD) NCT03296176 blood sample Runs in: France · 1 site |
NA other |
UNKNOWN | 150 | University Hospital, Angers OTHER_GOV |
2017-11-01 |
|
Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS NCT02678767 Ferumoxytol Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 30 | Beau Nakamoto OTHER |
2017-10-27 |
|
Early Nurse Detection and Management of Delirium NCT01505257 END-DSD Runs in: United States · 2 sites |
NA other |
COMPLETED | 391 | Penn State University OTHER |
2017-10-26 |
|
A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis NCT02035553 Pimavanserin tartrate; Placebo Runs in: United Kingdom · 1 site |
PHASE2 other |
COMPLETED | 181 | ACADIA Pharmaceuticals Inc. INDUSTRY |
2017-10-25 |
|
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers NCT01702467 GSK2647544; Placebo Runs in: Australia · 1 site |
PHASE1 other |
COMPLETED | 27 | GlaxoSmithKline INDUSTRY |
2017-10-18 |
|
Effects of Primary Prevention in Elderly People-The Healthy Aging Initiative NCT03312439 Given advice |
NA other |
UNKNOWN | 10,000 | Region Västerbotten OTHER_GOV |
2017-10-18 |
|
Therapeutic Role of Transcranial DCS in Alzheimer NCT03313518 tDCS; Sham tDCS |
NA other |
COMPLETED | 30 | Assiut University OTHER |
2017-10-18 |
|
Combination Treatment Study for Memory Impairment and Depression NCT01658228 Donepezil; Placebo; Citalopram; Venlafaxine Runs in: United States · 2 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 86 | New York State Psychiatric Institute OTHER |
2017-10-17 |
|
Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type NCT02168920 2 mg/day; 3 mg/day; 6 mg/day; Placebo (0 mg/day) Runs in: Japan · 1 site |
PHASE3 other |
TERMINATED | 150 | Otsuka Pharmaceutical Co., Ltd. INDUSTRY |
2017-10-16 |
|
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease NCT00099242 rivastigmine transdermal patch Runs in: Chile; Czechia; Denmark; Finland; Germany; Guatemala; Isr... · 75 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 1,040 | Novartis Pharmaceuticals INDUSTRY |
2017-10-13 |
|
MIG-HD: Multicentric Intracerebral Grafting in Huntington's Disease NCT00190450 graft intracerebral of foetal neurons Runs in: France · 1 site |
PHASE2 other |
COMPLETED | 54 | Assistance Publique - Hôpitaux de Paris OTHER |
2017-10-13 |
|
tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary Aphasia NCT02873546 transcranial Direct Current Stimulation (tDCS) Runs in: France · 3 sites |
NA other |
UNKNOWN | 52 | Centre Hospitalier Universitaire de Besancon OTHER |
2017-10-13 |
|
Self-Directed Online Training for Chinese Caregivers NCT03308032 Intervention; Control |
NA other |
UNKNOWN | 120 | Environment and Health Group, Inc. INDUSTRY |
2017-10-12 |
|
PERFECTED: Caring for Patients With Hip-fracture & Memory Difficulties NCT03308123 Observational study, not interventional Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 52 | University of East Anglia OTHER |
2017-10-12 |
|
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study NCT02256306 Plasma Runs in: United States · 1 site |
NA other |
COMPLETED | 18 | Stanford University OTHER |
2017-10-10 |
|
Talking Time: Telephone Support Groups for Informal Caregivers of People With Dementia NCT02806583 structured support groups Runs in: Germany · 1 site |
NA other |
COMPLETED | 38 | University of Leipzig OTHER |
2017-10-09 |
|
Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain NCT03080051 [18F]MNI-952; [18F]Florbetapir Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 6 | Molecular NeuroImaging OTHER |
2017-10-06 |
|
EXCEL: Exercise for Cognition and Everyday Living for Seniors With Memory Complaints NCT00958867 Exercise program (AT); Exercise training (RT); Exercise training (S... Runs in: Canada · 1 site |
NA other |
COMPLETED | 86 | University of British Columbia OTHER |
2017-10-04 |
|
Use of Intraoperative Clonidine for Prevention of Postoperative Agitation in Pedriatic Anesthesia With Sevoflurane. NCT02181543 Clonidine Runs in: Brazil · 1 site |
PHASE3 other |
COMPLETED | 30 | Professor Fernando Figueira Integral Medicine Institute OTHER |
2017-10-04 |
|
Behavioral and Environmental Sensing and Intervention NCT03297268 Intervention with Home-Based Caregivers Runs in: United States · 1 site |
NA other |
UNKNOWN | 24 | University of Virginia OTHER |
2017-09-29 |
|
Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes NCT03255720 |
NA other |
UNKNOWN | 40 | Assiut University OTHER |
2017-09-26 |
|
Ziprasidone vs Standard Therapy for Agitated Patients in the ED NCT00786318 ziprasidone; Standard therapy Runs in: United States · 1 site |
PHASE4 other |
WITHDRAWN | 0 | George Washington University OTHER |
2017-09-25 |
|
Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL) NCT00920699 CoQ10 Runs in: United States · 13 sites |
PHASE2 other |
COMPLETED | 90 | Johns Hopkins University OTHER |
2017-09-25 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial